CDK2 anticorps
Aperçu rapide pour CDK2 anticorps (ABIN2718388)
Antigène
Voir toutes CDK2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Homo sapiens cyclin-dependent kinase 2 (CDK2), transcript variant 1
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Full length human recombinant protein of human CDK2 (NP_001789) produced in HEK293T cell.
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- WB 1:2000, IHC 1:150, IF 1:100, FLOW 1:100
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- CDK2 (Cyclin-Dependent Kinase 2 (CDK2))
-
Autre désignation
- CDK2
-
Sujet
- The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein kinase is highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2. It is a catalytic subunit of the cyclin-dependent protein kinase complex, whose activity is restricted to the G1-S phase, and essential for cell cycle G1/S phase transition. This protein associates with and regulated by the regulatory subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A) and p27Kip1 (CDKN1B). Its activity is also regulated by its protein phosphorylation. Two alternatively spliced variants and multiple transcription initiation sites of this gene have been reported.
-
Poids moléculaire
- 33.7 kDa
-
ID gène
- 1017
-
NCBI Accession
- NM_001798
-
HGNC
- 1017
-
Pathways
- Signalisation PI3K-Akt, Cycle Cellulaire, Mitotic G1-G1/S Phases, DNA Replication, M Phase, Synthesis of DNA
Antigène
-